BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ballard DD, Choksi N, Lin J, Choi EY, Elmunzer BJ, Appelman H, Rex DK, Fatima H, Kessler W, DeWitt JM. Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection. World J Gastrointest Endosc 2016; 8(20): 763-769 [PMID: 28042390 DOI: 10.4253/wjge.v8.i20.763] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Otaki F, Iyer PG. Response. Gastrointest Endosc 2021;93:283-4. [PMID: 33353635 DOI: 10.1016/j.gie.2020.09.015] [Reference Citation Analysis]
2 Lu W, Li P, Wen W, Jian Y. Comparison of Long-Term Survival Between cT1N0 Stage Esophageal Cancer Patients Receiving Endoscopic Dissection and Esophagectomy: A Meta-Analysis. Front Surg 2022;9:917689. [DOI: 10.3389/fsurg.2022.917689] [Reference Citation Analysis]
3 Ekeke CN, Chan EG, Fabian T, Villa-Sanchez M, Luketich JD. Recommendations for Surveillance and Management of Recurrent Esophageal Cancer Following Endoscopic Therapies. Surg Clin North Am 2021;101:415-26. [PMID: 34048762 DOI: 10.1016/j.suc.2021.03.004] [Reference Citation Analysis]
4 Ilonen IK, Molena D. Gambling with esophageal cancer: May the odds be in your favor! J Thorac Cardiovasc Surg 2018;156:404-5. [PMID: 29576262 DOI: 10.1016/j.jtcvs.2018.02.052] [Reference Citation Analysis]
5 Azari FS, Roses RE. Management of Early Stage Gastric and Gastroesophageal Junction Malignancies. Surg Clin North Am. 2019;99:439-456. [PMID: 31047034 DOI: 10.1016/j.suc.2019.02.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Braun S, Ell C, Lorenz D. Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma. World J Surg. 2020;44:1192-1199. [PMID: 31853591 DOI: 10.1007/s00268-019-05291-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Nelson DB, Dhupar R, Katkhuda R, Correa A, Goltsov A, Maru D, Sepesi B, Antonoff MB, Mehran RJ, Rice DC, Vaporciyan AA, Davila M, Davila R, Betancourt S, Ajani J, Hofstetter WL. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2018;156:406-413.e3. [PMID: 29605441 DOI: 10.1016/j.jtcvs.2018.02.093] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
8 Schoeman S, Shahidi N, Bourke MJ. Snare-based full-thickness endoscopic resection for deeply invasive colorectal neoplasia. Gastrointest Endosc 2020;92:731-4. [PMID: 32838913 DOI: 10.1016/j.gie.2020.04.064] [Reference Citation Analysis]
9 Oza K, Peesay T, Greenspun B, Carroll JE, Shafa S, Zeck JC, Haddad NG, Margolis M, Khaitan PG. Long-term outcomes of endoscopic mucosal resection for early-stage esophageal adenocarcinoma. Surg Endosc 2021. [PMID: 34845554 DOI: 10.1007/s00464-021-08884-2] [Reference Citation Analysis]
10 Chu JN, Choi J, Tramontano A, Morse C, Forcione D, Nishioka NS, Abrams JA, Rubenstein JH, Kong CY, Inadomi JM, Hur C. Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: A Modeling Decision Analysis. Clin Gastroenterol Hepatol 2018; 16: 392-400. e7. [PMID: 29079222 DOI: 10.1016/j.cgh.2017.10.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
11 Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WL. Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer? Diseases of the Esophagus 2019;32:1-6. [DOI: 10.1093/dote/doz016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
12 Kumble LD, Silver E, Oh A, Abrams JA, Sonett JR, Hur C. Treatment of early stage (T1) esophageal adenocarcinoma: Personalizing the best therapy choice. World J Meta-Anal 2019; 7(9): 406-417 [DOI: 10.13105/wjma.v7.i9.406] [Reference Citation Analysis]
13 Otaki F, Ma GK, Krigel A, Dierkhising RA, Lewis JT, Blevins CH, Gopalakrishnan NP, Ravindran A, Johnson ML, Leggett CL, Wigle D, Wang KK, Falk GW, Abrams JA, Nakagawa H, Rustgi AK, Wang TC, Lightdale CJ, Ginsberg GG, Iyer PG. Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. Gastrointest Endosc 2020;92:31-39.e1. [PMID: 31953189 DOI: 10.1016/j.gie.2020.01.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]